Skip to content

Resistance Training and Testosterone After Spinal Cord Injury

Effects of Evoked Resistance Training and Testosterone After Spinal Cord Injury

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01652040
Enrollment
26
Registered
2012-07-27
Start date
2012-07-02
Completion date
2017-12-30
Last updated
2018-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injury

Keywords

Spinal Cord Injury, Rehabilitation, Electrical Stimulation, Testosterone, Body Composition, Lipid and Glucose profile, Ectopic Adiposity

Brief summary

The goal of this proposal is to investigate the efficacy of a complimentary approach of evoked resistance training and testosterone replacement therapy on the changes in body composition and metabolic profile after SCI. The proposed method could become a recommended and simple intervention especially for individuals with limited access and poor tolerance to exercise. The rationale is based on the evidence that individuals with SCI experience decline in anabolic hormones which may be responsible for the deterioration in body composition and metabolic profiles and leads to increase obesity, type 2 diabetes mellitus, dyslipidemia and subsequently cardiovascular disease. The designed study will provide explanation to the adaptations in the energy source of the muscle cells in response to training.

Detailed description

Individuals with spinal cord injury (SCI) are at a lifelong risk of increasing obesity and several chronic metabolic disorders such as glucose intolerance, insulin resistance and dyslipidemia secondary to deterioration in body composition. Within few weeks of injury, there are significant decrease in whole body fat-free mass (FFM), particularly lower extremity skeletal muscle mass and subsequent increase in fat mass (FM). Resistance training (RT) is an important type of exercise that has been shown to induce positive physiological adaptations such as increasing lean mass and reducing metabolic disorders in other clinical populations. In a pilot work, the investigators provided evidence that evoked RT using surface neuromuscular electrical stimulation (NMES) for knee extensor muscle group resulted in significant increase skeletal muscle cross-sectional area (CSA), reduction in % leg FM and a trend towards decrease in visceral adipose tissue (VAT) CSA. The favorable adaptations in body composition were associated with decrease in plasma insulin area under the curve and plasma triglycerides. The investigators attributed the adaptations in body composition and metabolic profile to an associated increase in plasma insulin-like growth factor (IGF-1). The investigators concluded that twelve weeks of evoked RT targeted towards evoking skeletal muscle hypertrophy could result in significant body composition and metabolic adaptations in individuals with SCI. It is unclear if a longer RT program greater than 12 weeks would provide additional benefits to Veterans with SCI. It is also unknown whether enhancing the decline anabolic homeostasis by providing testosterone (T) replacement therapy (TRT) would reverse body composition and metabolic profile changes in Veterans with SCI. The major research goal of this proposal is to investigate the effects of 16 weeks of evoked RT+TRT vs. TRT on body composition (muscle CSA, VAT, %FM) and the metabolic profiles (glucose and lipid metabolism) in individuals with motor complete SCI. To address this goal, surface NMES accompanied with ankle weights will be conducted twice weekly to exercise the knee extensor skeletal muscle groups from sitting position. After 4 weeks of delayed entry approach, participants (n =24) will be randomly assigned into RT+TRT (n =12) or TRT (n =12) groups. The TRT will be provided via transdermal T patches that will be alternated on both shoulders over the course of the study. The investigators also propose to study the effects of detraining on body composition and metabolic profiles. The research plan includes three specific aims Specific aim 1 will demonstrate the effects of NMES RT and/or Testosterone patches (Tp) on the CSA of thighs and legs skeletal muscle groups, percentage FFM, and the CSA of VAT, intramuscular fat and percentage FM after 16 weeks of training+Tp and 16 weeks of detraining. Specific aim 2 will determine the changes in metabolic milieu (resting energy expenditure, glucose homeostasis, lipid profile, free fatty acids, serum total and free testosterone and IGF-1), and cytokines (c-reactive protein, tumor necrosis factor alpha and IL-6 as inflammatory biomarkers) after 16 weeks of training+Tp and detraining. Specific aim 3 will determine if 16 weeks of evoked RT and Tp will increase GLUT-4 concentration, muscle IGF-1 and peroxisome-proliferator-activated receptor-gamma co-activator 1 (PGC-1) expressions, altered fiber type distribution and enhance the mitochondrial enzymatic activities (electron transport chain) compared to Tp only.

Interventions

DEVICEResistance Training and Testosterone Patches

We are going to activate the knee extensor muscle group to lift ankle weights over 16 weeks and we are going to provide Tp to improve anabolic profile.

DRUGTestosterone Patches

The investigators will provide Tp patches for 16 weeks for patients with Spinal Cord Injury.

Sponsors

Virginia Commonwealth University
CollaboratorOTHER
VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
MALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Male with Spinal Cord Injury * Between 18-50 years old * BMI \< 30 Kg/m2 * Traumatic motor complete C5-L2 level of injury * American Spinal Injury Classification (A and B; i.e. motor deficit below the level of injury)

Exclusion criteria

* Cardiovascular disease * Uncontrolled type II DM and those on insulin * Pressures sores stage 2 or greater * Supra-physiological T level * Hematocrit above 50% * Urinary tract infection or symptoms

Design outcomes

Primary

MeasureTime frameDescription
Body Composition16 weeksChanges in body composition fat mass

Secondary

MeasureTime frameDescription
Metabolic Profile16 weeksBasal Metabolic Rate

Countries

United States

Participant flow

Participants by arm

ArmCount
RT+Tp
Resistance training using electrical stimulation and ankle weights and Testosterone patches Resistance Training and Testosterone Patches: We are going to activate the knee extensor muscle group to lift ankle weights over 16 weeks and we are going to provide Tp to improve anabolic profile.
11
Testosterone Replacement Patches (Tp)
Applying Testosterone patches Testosterone Patches: The investigators will provide Tp patches for 16 weeks for patients with Spinal Cord Injury.
11
Total22

Baseline characteristics

CharacteristicRT+TpTestosterone Replacement Patches (Tp)Total
Age, Continuous37 years
STANDARD_DEVIATION 12
35 years
STANDARD_DEVIATION 8
36 years
STANDARD_DEVIATION 10
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
4 Participants4 Participants8 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
7 Participants7 Participants14 Participants
Region of Enrollment
United States
11 Participants11 Participants22 Participants
Sex: Female, Male
Female
0 Participants0 Participants0 Participants
Sex: Female, Male
Male
11 Participants11 Participants22 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 130 / 13
other
Total, other adverse events
0 / 130 / 13
serious
Total, serious adverse events
0 / 130 / 13

Outcome results

Primary

Body Composition

Changes in body composition fat mass

Time frame: 16 weeks

ArmMeasureGroupValue (MEAN)Dispersion
RT+TpBody CompositionBaseline31.84 percentage of fat massStandard Deviation 10.7
RT+TpBody CompositionPost-Intervention (After 16 weeks)30.75 percentage of fat massStandard Deviation 10.3
Testosteroe Replacement Patches (Tp)Body CompositionBaseline33.4 percentage of fat massStandard Deviation 9
Testosteroe Replacement Patches (Tp)Body CompositionPost-Intervention (After 16 weeks)32.12 percentage of fat massStandard Deviation 9
Secondary

Metabolic Profile

Basal Metabolic Rate

Time frame: 16 weeks

ArmMeasureGroupValue (MEAN)Dispersion
RT+TpMetabolic ProfileBaseline1525 kcal/dayStandard Deviation 261
RT+TpMetabolic ProfilePost-Intervention (After 16 weeks)1665 kcal/dayStandard Deviation 243
Testosteroe Replacement Patches (Tp)Metabolic ProfileBaseline1491 kcal/dayStandard Deviation 177
Testosteroe Replacement Patches (Tp)Metabolic ProfilePost-Intervention (After 16 weeks)1502 kcal/dayStandard Deviation 327

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026